WO2007086307A1

WO2007086307A1 - Chemical-volatilizing apparatus

Info

Publication number: WO2007086307A1
Application number: PCT/JP2007/050728
Authority: WO
Inventors: Aya Suzuki; Takahiro Hasegawa
Original assignee: Earth Chemical Co., Ltd.
Priority date: 2006-01-26
Filing date: 2007-01-18
Publication date: 2007-08-02
Also published as: JPWO2007086307A1

Abstract

A chemical-volatilizing apparatus size of which can be reduced, and which can be installed easily in a narrow space, and transportable easily. The chemical-volatilizing apparatus (10) comprises a case (11) having suction ports (20, 21) and discharge ports (22, 22), a cross flow fan (14) disposed in the case (11) and connected to the rotating shaft (15a) of a motor (15), and a chemical holding body (17) disposed on the suction port (20, 21) side of the case (11) in parallel with the longitudinal direction of the cross flow fan (14).

Description

Specification

Chemical volatilization device

Technical field

TECHNICAL FIELD [0001] The present invention relates to a chemical volatilization device, and more particularly to a chemical volatilization device incorporating a fan.

Background art

[0002] Conventionally, a chemical volatilization device for volatilizing a chemical for the purpose of insect control has been used. As a conventional chemical volatilization device, a box is installed on a stand, and a sterilization formed in the box. The room is equipped with a germicidal lamp, with a built-in crossflow fan and filter inside the box (see, for example, Patent Document 1), or a crossflow fan with a photoactive catalyst fixed to the blade. In addition, a cross flow fan and a UV lamp (for example, see Patent Document 2), or a main body case containing a cross flow fan and a deodorizing element (for example, see Patent Document 3). ) Etc. are known.

Patent Document 1: Japanese Patent Application Laid-Open No. 8-720

Patent Document 2: Japanese Patent Laid-Open No. 10-211268

Patent Document 3: Japanese Unexamined Patent Publication No. 2005-230043

Disclosure of the invention

Problems to be solved by the invention

[0004] However, the chemical volatilization devices described in Patent Documents 1 to 3 are all floor-mounted chemical volatilization devices that are used on the floor and are large and installed in a narrow place. Since it is difficult to carry, miniaturization of the device is strongly desired.

[0005] The present invention has been made to eliminate such inconveniences, and the object of the present invention is to reduce the size of the device and to easily install it in a narrow place. An object of the present invention is to provide a drug volatilization device that can be easily carried.

Means for solving the problem

[0006] The above object of the present invention is achieved by the following configurations.

(1) A case having an air inlet and an air outlet, a cross flow fan disposed in the case and connected to the rotating shaft of the motor, parallel to the longitudinal direction of the cross flow fan and the case And a medicine holder disposed on the inlet side.

(2) The chemical volatilization device according to (1), wherein an intake port and an exhaust port are arranged at a position parallel to the longitudinal direction of the cross flow fan.

(3) The case is a portable cylindrical member, in which a cross flow fan is arranged on one side in the longitudinal direction of the case, and a battery for driving the motor is arranged on the other side in the longitudinal direction of the case. The chemical volatilization device according to (1) or (2), characterized in that it is characterized.

(4) The drug volatilization device according to any one of (1) to (3), wherein the case has an indicator for confirming the remaining amount of the drug in the drug holder.

According to the chemical volatilization device described in (1) above, a case having an intake port and an exhaust port, a cross flow fan disposed in the case and connected to the rotating shaft of the motor, and the cross flow fan Since the crossflow fan and the medicine holder are arranged in parallel, the apparatus can be miniaturized. Thereby, it can be easily installed in a narrow place and can be easily carried.

According to the chemical volatilization device described in (2) above, since the intake port and the exhaust port are arranged at a position parallel to the longitudinal direction of the cross flow fan, the air blown by the cross flow fan is sent from the intake port. When it is introduced, it passes through the medicine holder placed on the inlet side, blown to the crossflow fan, and the exhaust outlet force also releases the medicine to the outside. As a result, air can be efficiently introduced from the intake port to the crossflow fan, and air can be efficiently blown from the crossflow fan to the exhaust port, so that the drug in the drug holder is efficiently vaporized. be able to.

According to the chemical volatilization device described in (3) above, the case is a portable cylindrical member, the cross flow fan is arranged on one side in the longitudinal direction of the case, and on the other side in the longitudinal direction of the case. Since the battery for driving the motor is arranged, the device can be miniaturized into a long and thin shape and can be carried like a pen.

According to the chemical volatilization device described in (4) above, since the case has an indicator for confirming the remaining amount of the medicine in the medicine holder, it is possible to check the replacement time of the medicine holder. For example, by coloring the drug held in the drug holder, During use, it is possible to check the color of the drug holder, which is an indicator window, to check the replacement time of the drug holder, etc., and to check the remaining amount of the drug using the LED.

The invention's effect

[0008] According to the chemical volatilization device of the present invention, a case having an intake port and an exhaust port, a cross flow fan disposed in the case and connected to the rotating shaft of the motor, and a longitudinal direction of the cross flow fan And a medicine holder disposed on the inlet side of the case, the device can be miniaturized, can be easily installed in a narrow place, and is easily portable. can do.

Brief Description of Drawings

FIG. 1 is an external perspective view for explaining a first embodiment of a chemical volatilization device according to the present invention.

FIG. 2 is a front view of the chemical volatilization device shown in FIG.

FIG. 3 is a right side view of the chemical volatilization device shown in FIG. 1.

FIG. 4 is a front view of the chemical volatilization device shown in FIG. 1 with its cover removed.

FIG. 5 is a cross-sectional view taken along line AA in FIG.

FIG. 6 shows a second embodiment of the chemical volatilization device according to the present invention, (a) is a front view of the chemical volatilization device with the cover removed, and (b) is a cross-sectional view of the chemical volatilization device. It is.

FIG. 7 is a front view of the third embodiment of the chemical volatilization device according to the present invention with the cover removed.

FIG. 8 is an external perspective view for explaining a fourth embodiment of the chemical volatilization device according to the present invention.

Explanation of symbols

[0010] 10, 50, 60, 70 Drug volatilization device

Case

-7 "~~ su body

cover

Cross flow fan

motor 15a Rotating shaft

15b, 15c brush terminal

16, 61 battery

17, 77 Drug carrier

18, 62 switches

20, 21, 72 Air intake

22, 73 Volatilization port (exhaust port)

23 Fan compartment

24 Motor fixing part

25 Battery compartment

26 Medicine holder storage

27 Inspection window (indicator)

BEST MODE FOR CARRYING OUT THE INVENTION

Hereinafter, each embodiment of the chemical volatilization device according to the present invention will be described in detail with reference to the drawings.

[0012] (First embodiment)

First, with reference to FIGS. 1-5, 1st Embodiment of the chemical volatilization apparatus which concerns on this invention is described.

FIG. 1 is an external perspective view for explaining a first embodiment of a drug volatilization apparatus according to the present invention, FIG. 2 is a front view of the drug volatilization apparatus shown in FIG. 1, and FIG. 3 is a right side of the drug volatilization apparatus shown in FIG. FIG. 4 is a front view of the chemical volatilization apparatus shown in FIG. 1 with the cover removed, and FIG. 5 is a cross-sectional view taken along line AA in FIG.

As shown in FIGS. 1 to 4, the chemical volatilization device 10 of this embodiment includes a case 11 having a case body 12 and a cover 13, a cross flow fan 14 disposed in the case 11, and a motor. 15, a battery 16, a medicine holder 17, and a switch 18 disposed on a side surface of the case 11 (right side surface in FIG. 1).

[0014] The case 11 is a cylindrical member having a substantially egg-shaped cross section, and is formed into a slender pen shape as a whole, and a cover 13 is attached to the case main body 12 so as to form an integral structure. Structure Made. As a result, the battery 16 and the medicine holder 17 can be easily replaced simply by removing the cover 13 from the case body 12. The case 11 has a length L of about 90 mm to 130 mm, a width B of about 20 mm to 30 mm, and a thickness D of about 15 mm to 20 mm.

[0015] In addition, the case 11 has air inlets 20 and 21 formed in parallel to the crossflow fan 14 on the side surface (right side surface in FIG. 2), and the front surface (left side surface portion in FIG. 3). Volatilization ports 22 and 22 as exhaust ports are formed at positions parallel to the crossflow fan 14). Among these, the air inlet 20 and the volatilization ports 22 and 22 are formed in the cover 13, and the air inlet 21 is formed in the case body 12. In addition, the intake ports 20 and 21 and the volatilization ports 22 and 22 are formed in a slit shape so that the width decreases toward the end.

As shown in FIG. 4, the case main body 12 has a longitudinal force in one side, a fan housing portion 23 for housing the crossflow fan 14 and a motor for fixing the motor 15 toward the other side. A fixing portion 24 and a battery storage portion 25 for storing the battery 16 are formed, and the cross flow fan 14, the motor 15, and the battery 16 are arranged in a row. In addition, a medicine holder housing part 26 for housing the medicine holder 17 is formed in parallel with the fan housing part 23. Further, the switch 18 is assembled to the side of the motor fixing portion 24 (the right side in FIG. 4).

In addition, a substantially circular inspection window 27 is formed on the upper surface of the case body 12 (upper surface in FIG. 4) as an indicator for confirming the remaining amount of the medicine in the medicine holder 17. The inspection window 27 is used for visually observing the color of the medicine held on the medicine holder 17 and can check the remaining amount of medicine in the medicine holder 17. The indicator may be an LED for checking the remaining amount of medicine.

[0018] The cross flow fan 14 is incorporated in the fan housing part 23 of the case body 12, and the rotary shaft 15a of the motor 15 is connected to the end part (the lower end part in FIG. 4) of the cross flow fan 14. The In the present embodiment, the cross flow fan 14 takes in air from the air inlets 20 and 21 on the side surface of the case 11 and changes the direction of the taken air by approximately 90 ° to volatilize the front portion of the case 11. It blows in the direction of mouths 22 and 22.

The motor 15 is a DC brush motor, and is fixed to the motor fixing portion 24 of the case body 12. It is. Then, when current is supplied to the pair of brush terminals 15b and 15c, the rotating shaft 15a rotates, and the cross flow fan 14 connected to the rotating shaft 15a is driven. Depending on the type and size of the motor 15, a connecting member that can be freely curved may be used as a connecting member that connects the cross flow fan 14 and the rotating shaft 15a of the motor 15. As a result, a drug volatilization device having a curved shape can be obtained.

[0020] The battery 16 is housed in the battery housing part 25 of the case body 12 so as to be aligned on the axis of the crossflow fan 14 and the motor 15, and supplies current to the motor 15 when the switch 18 is turned on. Then, the motor 15 is rotated. In the present embodiment, the battery 16 uses a single AAA-type disposable or rechargeable battery, but a rechargeable battery pack may be used as long as it is a power source capable of obtaining necessary power. Moreover, the size and number of batteries are arbitrary.

[0021] As shown in FIG. 5, the drug holder 17 is a rod-shaped member having a substantially circular cross section along the intake ports 20, 21, and is attached to the drug holder storage part 26 of the case body 12. The cross flow fan 14 is arranged in parallel with the longitudinal direction of the case 11 and on the side of the intake ports 20 and 21 of the case 11. The medicine holder 17 holds a pre-colored medicine. The drug holder 17 may be a rod-like member, and its cross-sectional shape is arbitrary. Further, the medicine holder 17 may be covered with a breathable cover which may be housed in a breathable packaging material. In this case, the shape of the drug holder 17 may be any shape that can be stored in a breathable packaging material such as powder, granules, tablets, capsules, tablets, and the like. Further, the medicine holder 17 may be a blade itself of the cross flow fan 14 or a part of a structure of the cross flow fan 14. In this case, since it is not necessary to arrange the medicine holder 17 on the side of the intake ports 20 and 21, it is possible to further downsize the apparatus.

[0022] The material of the drug holder 17 is not particularly limited as long as it can sufficiently hold the active ingredient, but it is the same amount over a desired period of time as compared with a substance that volatilizes the held active ingredient at once. A material that continuously volatilizes the active ingredient is preferable. Specifically, paper (filter paper, norp, linter, cardboard, cardboard, etc.), greaves (polyethylene, polypropylene, polyvinyl chloride, highly oil-absorbing polymer, etc.), ceramic, glass fiber, carbon fiber, chemical fiber (Polyester, nylon, acrylic, vinylon, polyethylene, polypropylene, etc.), natural fiber

(Cotton, silk, wool, hemp, etc.), glass fiber, carbon fiber, chemical fiber, natural fiber, etc. Examples thereof include cotton such as woven fabric and knitted fabric, porous glass material, porous metal material, and wire mesh.

Examples of the active ingredient of the drug to be held in the drug holding body 17 include pest control agents, bactericides, fragrances, deodorants and the like. Typical examples of pest control ingredients are shown below.

• dl— 3 allyl 1- 2 — methyl 4 oxo 2 cyclopentale dl -cis Z trans — Chrysanthemate (generic name Areslin: trade name pinamine: manufactured by Sumitomo Chemical Co., Ltd.) • dl— 3 allyl 1- 2-methyl 4 —Oxo 2 cyclopentale d—cis Z trans Chrysanthemate (trade name: Pinamin Forte: manufactured by Sumitomo Chemical Co., Ltd.) • dl— 3 Allyru 2—Methyl-4 Oxoso 2 Cyclopentenyl d—Trans 1 Tari Sante Mart (general) Name: Bioareslin, trade name: Esbviol: manufactured by Uttaraf) • d— 3 allylo-2-methyl-4 oxo-2 cyclopentenyl d-trans chrysanthemate (trade name: Exrin: manufactured by Sumitomo Chemical Co., Ltd.)

• (5-Benzyl-1-3-furyl) methyl d-cis Z-trans-Chrysanthemate (generic name Resmetrine: trade name Kryslon Forte: manufactured by Sumitomo Chemical Co., Ltd.)

.5 -propargyl 2-furylmethyl d-cis / trans chrysanthemate (generic name: frametrin: trade name pinamine D forte: manufactured by Sumitomo Chemical Co., Ltd.)

• (+) —2—Methinore 1—Oxo 3— (2 Propinore) 2 Cyclopentenore (+) -cis Z Trans-Chrysantemate (generic name Praretrin, trade name Etok: Sumitomo Chemical Co., Ltd Made)

• dl— 3 aryl 1- 2-methyl 4-oxo 2 cyclopenterolu dl—cis / trans 2, 2, 3, 3-tetramethylcyclopropanecarboxylate (generic name: Terrareslin: manufactured by Sumitomo Chemical Co., Ltd.)

• (1, 3, 4, 5, 6, 7 Hexahydro 1,3 Dioxo 1-isoindolyl) methyl dl —cis / trans-Chrysantemate (generic name phthalusrin, trade name Neopinamine: manufactured by Sumitomo Chemical Co., Ltd.) )

• (1, 3, 4, 5, 6, 7 Hexahydro 1,3-Dioxo 1-isoindolyl) methyl d cis Z trans Chrysantemate (trade name Neopinamine Forte: Sumitomo Chemical Co., Ltd.) (Made by company)

• 3—Phenoxybenzyl 1-d / cis / trans-Chrysantemate (generic name Phenothrin, trade name Smithin: manufactured by Sumitomo Chemical Co., Ltd.)

• 3 Phenoxybenzyl 1 dl—cis / trans 1 3 — (2,2 dichlorobutyl) 1, 2, 2 —dimethyl 1 1-cyclopropanecarboxylate (generic name permethrin, trade name Tasmin: Sumitomo Chemical Co., Ltd.) Made)

• (±) α-Cyanol 3—Phenoxybenzyl (+) — Cis クリ Trans-Crysantemate (generic name: Siphenothrin, trade name: Gokyrat: manufactured by Sumitomo Chemical Co., Ltd.)

• 1—Etul— 2—Methyl—2 Pentayl dl—Cis / trans— 3— (2, 2 Dimethylvinyl) 2, 2—Dimethyl 1-cyclopropanecarboxylate (generic name: Pentoline, trade name) Beth Perslin: Sumitomo Chemical Co., Ltd.)

• d—trans 1, 2, 5, 5, 6—tetrafluorobenzyl 1— (2,2 dichlorobutyl) 1, 2, 2—dimethyl 1—cyclopropanecarboxylate (generic name transfluthrin) • 1— Etul-2-methyl-2 pentyl 3- (2,2 dichloroethyl) -2,2-dimethylcyclopropanecarboxylate and the like.

In addition, for example, compounds having structurally similar and substantially similar medicinal properties can be mentioned. For example, in the case of empentrin, the two substituents at the 3-position are methyl groups, but compounds having other alkyl groups, unsaturated alkyl groups or halogen atoms as the substituents can also be used. In addition, fiproneil, imiprothrin, dinotefuran (a scientific name: (RS) 1-methyl 2 -toro 1- (tetrahydro 1-furylmethyl) guanidine), trichlorfone , Cartap, acetamiprid, imidacloprid (Imidacloprid, manufactured by Nippon Bayer Grochem), Nitenp yram (manufactured by Sumika Takeda Agrochemicals), thiacloprid (made by Bayer Grochem, Japan), clothiazine ( Clotianidin (manufactured by Sumika Takeda Agrochemicals), thiamethoxam (Thiame thoxam, manufactured by Syngentane), propoxur (Propoxur, manufactured by Bayer Yakuhin), pimetrozine (manufactured by Syngentane), fe-trothion (manufactured by Sumitomo Chemical), Fenthion (Bayer), Metofluthrin (Sumitomo Chemical), Profluthrin (Sumitomo Chemical) , Amidoflumet (manufactured by Sumitomo Chemical Co., Ltd.), pesticide chrysanthemum extract, plant essential oil and other insecticides and Len (isopropyl (2E—2E) —11—methoxy-1,3,7,11 trimethyl-2,4 trimethyldodeca-1,4 dienoate), pyriproxyfen, 82— [1-methyl-2- (phenoxyphenoxy) ethoxy] pyridine ) Insect Juvenile Hormone, Diflupenzuron (1 (4 black mouth ferrule)-3- (2, 6 Difluo mouth Benzoyl) urea), Teflubensron (1-(3, 5 Difluo mouth Benzoyl)) Insect chitin formation-inhibiting compounds such as urea).

[0025] Among these, those that are volatile at room temperature (vapor pressure 1. OX 10 ^1-2 ~ 1. OX 10 ^_6 mmHg) are preferred, and praretrin, resmethrin, bioareslin, framethrin, terrareslin, trans Fruthrin, metfurthrin, and profluthrin are particularly preferred. Such pest control components may be used alone or in combination. These analogs are also used. Of these, those that are likely to volatilize at room temperature include, for example, a cover for adjusting volatilization, hydrocarbons such as polybutene, isoparaffin, normal paraffin, hexyl laurate, isopropyl myristate, and phthalic acid. By using together with a volatilization regulator that also has an ester power, such as butyl, it becomes difficult to volatilize and a pest control effect can be obtained for a long time.

[0026] As an additive for reducing the viscosity of a liquid drug for the purpose of easily retaining the drug, fatty acid esters such as isopropyl myristate, isopropyl palmitate, hexyl laurate, isopropyl alcohol, polyethylene glycol, deodorized kerosene Solvents such as can be used as needed. In addition, when the drug is held, it can be held together with other auxiliary components. For example, if a sublimable substance is added as an auxiliary for transpiration, the volatilization effect may be enhanced. When using a pyrethroid compound as a pest control component, it is also preferable to mix a known synergist effective against this. Furthermore, the addition of antioxidants such as BHT and BHA and UV absorbers increases the stability to light, heat and acid.

[0027] In addition, the drug holder 17 allows the drug holder 17 to hold an active ingredient or the like by a liquid coating method such as drop coating, impregnation coating, spray coating, or the like. A method such as brushing or a method of attaching to the medicine holder 17 can be used. Furthermore, if the composition of the drug used is not liquid, or do not use a solvent. In such a case, methods such as kneading, coating, and printing can be applied.

[0028] The amount of the active ingredient held in the drug holding body 17 is usually up to the saturated impregnation amount of the drug holding body 17, but a separate replenishing container is connected to the drug holding body 17 via a liquid absorbing material. By doing so, it can be made into a form that can be used until the liquid in the container is continuously exhausted over a long period of time.

[0029] The switch 18 is a slide-type switch, and includes a movable plate 31 on which the operation unit 30 is formed, a contact plate 32 that is a movable contact fixed to the back surface of the movable plate 31, and the contact plate. First and second contactors 33 and 34 that are electrically separated from and connected to 32, and first, second and third bus bars 35, 36 and 37 made of three conductive metals. In the present embodiment, a force using a slide switch for the switch 18 may be replaced with a snap switch or a button switch.

[0030] The movable plate 31 is slidably assembled in a guide groove 38 formed in the case body 12, and slides together with the contact plate 32 as the operating portion 30 is pressed.

[0031] The first contactor 33 is electrically connected to one end of the first bus bar 35, and the other end of the first bus bar 35 is electrically connected to one brush terminal 15b of the motor 15. ing.

[0032] The second contactor 34 is electrically connected to one end of the second bus bar 36, and the other end of the second bus bar 36 is electrically connected to the negative side of the battery 16 in the battery housing 25. It is connected.

[0033] The third bus bar 37 has one end portion electrically connected to the other brush terminal 15c of the motor 15, and the other end portion electrically connected to the plus side of the battery 16 in the battery housing portion 25. ing.

In the chemical volatilization apparatus 10 configured as described above, as shown in FIG. 1, by sliding the operation unit 30 to the on position, the electric power of the battery 16 is positive side of the battery 16 → the third bus bar. 37 → Brush terminal of motor 15 15c → Brush terminal of motor 15 15b → First bus bar 35 → First contactor 33 → Contact plate 32 → Second contactor 34 → Second bus bar 36 → Flow in the negative direction of battery 16 . As a result, the rotating shaft 15a of the motor 15 rotates and the The sflow fan 14 is driven. Then, when the cross flow fan 14 is driven, external air is introduced into the cross flow fan 14 via the intake ports 20 and 21 and the medicine holder 17 as shown by arrows in FIG. The air blown by the flow fan 14 releases the chemical volatilized from the chemical carrier 17 through the volatilization ports 22 and 22 to the outside.

Further, by sliding the operating unit 30 from the on position to the off position in the front direction in FIG. 1, the contact plate 32 slides together with the movable plate 31, and the first contactor 33 is moved from the contact plate 32. Since it leaves, the energization circuit is cut off and the motor 15 stops.

Therefore, according to the chemical volatilization device 10 of the present embodiment, the case 11 having the intake ports 20 and 21 and the volatilization ports 22 and 22 are arranged in the case 11 and connected to the rotating shaft 15a of the motor 15. Cross flow fan 14 and drug holding body 17 that is parallel to the longitudinal direction of cross flow fan 14 and disposed on the side of intake ports 20 and 21 of case 11. Since the body 17 is arranged in parallel, the device 10 can be reduced in size. As a result, it can be easily installed in a narrow place and can be easily carried.

[0037] Also, according to the chemical volatilization device 10 of the present embodiment, since the intake ports 20, 21 and the volatilization ports 22, 22 are arranged in a position parallel to the longitudinal direction of the cross flow fan 14, the cross flow fan The air blown by 14 passes through the medicine holding body 17 arranged on the intake ports 20 and 21 side when introduced from the intake ports 20 and 21, and is blown to the cross flow fan 14 to the volatilization ports 22 and 2 2 to release the drug to the outside. As a result, air can be efficiently introduced from the intake ports 20 and 21 to the crossflow fan 14 and air can be efficiently blown to the volatilization ports 22 and 22 by the crossflow fan 14 force. It can efficiently volatilize 17 drugs.

[0038] Further, according to the chemical volatilization device 10 of the present embodiment, the case 11 is a portable cylindrical member, and the cross flow fan 14 is disposed on one side of the case 11 in the longitudinal direction. Since the battery 16 for driving the motor 15 is arranged on the other side in the longitudinal direction, the device 10 can be made thin and small in size, and can be carried like a pen.

[0039] Further, according to the drug volatilization apparatus 10 of the present embodiment, the case 11 has the inspection window 27 as an indicator for confirming the remaining amount of the drug in the drug holder 17, so that the drug holder It is possible to check 17 replacement times. For example, by coloring the medicine held in the medicine holder 17, the color of the medicine holder 17 is checked from the inspection window 27 that is an indicator at the time of use, and the replacement time of the medicine holder 17 is determined. Can be confirmed.

[0040] Furthermore, according to the drug volatilization apparatus 10 of the present embodiment, since the drug volatilization apparatus 10 is of a size that is easy to carry, the apparatus 10 can be carried in a pocket such as a jacket or pants. it can. In addition, for example, a string can be tied to the case 11, and the string can be wrapped around the neck, suspended in front of the chest, or wrapped around the wrist or arm. Furthermore, for small spaces such as rooms, it can be pasted around a desk or sink, hanging, or installed around a window frame or door frame.

[0041] (Second Embodiment)

Next, with reference to FIG. 6, a drug volatilization apparatus 50 according to a second embodiment of the present invention will be described. Note that portions overlapping with those of the first embodiment are denoted by the same reference numerals in the drawings, and description thereof is omitted or simplified.

FIG. 6 shows a second embodiment of the chemical volatilization apparatus according to the present invention, (a) is a front view of the chemical volatilization apparatus with the cover removed, and (b) is a sectional view of the chemical volatilization apparatus. is there.

[0042] As shown in FIG. 6, the chemical volatilization apparatus 50 of the present embodiment is provided with a battery housing part 25 on the side of the motor fixing part 24 (on the right side in FIG. 6) to connect the motor 15 and the battery 16 together. They are arranged in parallel. In addition, the switch 18 is arranged on the side surface of the case 11 on the motor 15 side (left side surface in FIG. 6).

[0043] According to the drug volatilization apparatus 50 of the present embodiment, the cross flow fan 14 and the drug holding body 17 are arranged in parallel, and the motor 15 and the battery 16 are arranged in parallel, so that the drug volatilization of the first embodiment is performed. The length can be shorter than that of the device 10. Thereby, the portability of the apparatus can be improved.

Other configurations and operational effects are the same as those in the first embodiment.

[0044] (Third embodiment)

Next, with reference to FIG. 7, a chemical volatilization apparatus 60 that is a third embodiment of the present invention will be described. Note that portions overlapping with those of the first embodiment are denoted by the same reference numerals in the drawings, and description thereof is omitted or simplified. FIG. 7 is a front view of the third embodiment of the chemical volatilization device according to the present invention with the cover removed.

As shown in FIG. 7, the chemical volatilization device 60 of the present embodiment is provided with a battery housing part 25 on the side of the motor fixing part 24 (right side in FIG. 7), and the battery housing part 25 has a button type. Batteries 61, 61 are stored alternately. In addition, a switch 62 is disposed on the side of the battery storage unit 25 (on the right side in FIG. 7). As a result, the motor 15, the batteries 61 and 61, and the switch 62 are arranged in parallel.

The switch 62 fixes the first contactor 63 to the movable plate 31, and the first contactor 63 is always electrically connected to the second contactor 64. In addition, the first bus bar 66 for conduction is electrically connected to one side of the batteries 61, 61 (left side in FIG. 7), and the first contactor 63 is detachably arranged on the positive side of the one battery 61. The third contactor 65 is electrically connected to the negative side of the other battery 61. Further, the second contactor 64 is electrically connected to the brush terminal 15c of the motor 15 via the second bus bar 67, and the third contactor 65 is electrically connected to the brush terminal 15b of the motor 15 via the third bus bar 68. Connected.

In the chemical volatilization device 60 configured as described above, as shown in FIG. 7, by sliding the operation unit 30 to the on position, the electricity of the batteries 61, 61 is changed to the plus side of the one battery 61. → first contactor 63 → second contactor 64 → second bus bar 67 → brush terminal 15c of motor 15 → brush terminal 15b of motor 15 → third bus bar 68 → third contactor 65 → negative side of the other battery 61 It flows in. As a result, the rotation shaft 15a of the motor 15 rotates and drives the crossflow fan 14. Also, by sliding the operation unit 30 from the on position to the off position in the forward direction in FIG. 7, the first contactor 63 slides together with the movable plate 31, and the first contactor 63 is connected to the one of the batteries 61. Since it is away from the positive side, the energization circuit is cut off and the motor 15 stops.

Therefore, according to the drug volatilization device 60 of the present embodiment, the cross flow fan 14 and the drug holding body 17 are arranged in parallel, and the motor 15, the batteries 61 and 61, and the switch 62 are arranged in parallel. In addition, since a button-type battery is used for the batteries 61 and 61, the length can be further shortened compared to the drug volatilization apparatuses 10 and 50 of the first and second embodiments. Thereby, the portability of the apparatus can be further improved. Other configurations and operational effects are the same as those in the first embodiment.

[0049] (Fourth embodiment)

Next, with reference to FIG. 8, a chemical volatilization apparatus 70 according to a fourth embodiment of the present invention will be described. Note that portions overlapping with those of the first embodiment are denoted by the same reference numerals in the drawings, and description thereof is omitted or simplified.

FIG. 8 is an external perspective view for explaining a fourth embodiment of the chemical volatilization apparatus according to the present invention.

As shown in FIG. 8, the chemical volatilization apparatus 70 of the present embodiment includes a case 71 having a first case portion 75 and a second case portion 76, and a cross flow disposed in the first case portion 75. A fan 14 and a motor 15, a battery 16 disposed in the second case portion 76, and a medicine holder 77 attached to the second case portion 76 are provided.

[0051] The case 71 is a cylindrical member having a substantially circular cross section, and is formed in an elongated pen shape as a whole. The case 71 is assembled by assembling the second case portion 76 to the first case portion 75. Composed. Thereby, the battery 16 and the medicine holder 77 can be exchanged at a time only by removing the second case portion 76 from the first case portion 75.

[0052] Inside the first case portion 75, the cross flow fan 14 and the motor 15 are arranged so as to be aligned in the longitudinal direction, and on the side surface portion of the first case portion 75, a plurality of air inlets 72, 72 and One volatilization port 73 is formed.

A drug holding frame 78 for attaching the drug holding body 77 is formed on one side in the longitudinal direction of the second case portion 76, and the battery 16 is placed on the other side in the longitudinal direction of the second case portion 76. Built-in. In addition, a switch (not shown) is assembled to the other side surface portion of the second case portion 76.

[0054] The drug holding body 77 is a planar member along the air inlets 72, 72, and is attached to the drug holding frame 78 of the second case 76, and is parallel to the longitudinal direction of the cross flow fan 14. It is arranged on the intake port 72, 72 side of the case 71. Note that the same drug as that in the first embodiment described above is used as the drug held by the drug holding body 77.

[0055] In the chemical volatilization device 70 configured in this way, the second case portion 76 is assembled to the first case portion 75 to form an integrated structure case 71. The cross-flow fan 14, the motor 15, and the battery 16 are arranged in a row with the force toward the side. Further, during assembly, the motor 15 in the first case portion 75 and the battery 16 in the second case portion 76 are electrically connected, and the motor (not shown) is turned on, so that the motor The 15 rotating shafts 15a rotate to drive the cross flow fan 14.

Therefore, according to the drug volatilization apparatus 70 of the present embodiment, the first case part 75 containing the cross flow fan 14 and the motor 15, the battery 16, and the medicine holder 77 is attached. 2 case part 76, and the second case part 76 is assembled to the first case part 75 to form an integrally structured case 71. Therefore, the device 10 can be further reduced in size, and the first case By simply removing the second case portion 76 from the portion 75, the battery 16 and the medicine holder 77 can be replaced at a time. Note that the battery 16 is a button battery, and the second case 76 is sized accordingly.

Other configurations and operational effects are the same as those in the first embodiment. Example

[0057] Hereinafter, the volatilization test conducted for confirming the action and effect of the volatile drug container of the present invention (this example) will be described.

[0058] The present example used in this test is the volatile drug container 70 of the fourth embodiment, and the reference example inhales the drug holder 77 of the volatile drug container 70 of the fourth embodiment. Volatilization port (exhaust port) connected on the 72 and 72 side is arranged on the 73 side. The drug carrier 77 is a Toray polyester mesh (T1107 / 888, size 15 × 40 mm, one layer) impregnated with 20 mg of metfurthrin. Furthermore, the voltage applied to the motor 15 was 1.5V.

[0059] In this test, each of this example and reference example was prepared, and each was driven to measure the air volume and the chemical volatilization amount. The results are shown in Table 1.

[0060] [Table 1] This Example Reference Example Placement of the drug carrier Inlet side Volatilization side

Air volume (S) 0. 43 0. 61 Volume of drug volatilization (mg / hr) 0. 06 0. 03

[0061] As is clear from Table 1, the reference example had an air volume of 0.61 liter Zsec and a chemical volatilization volume of 0.03 mgZhr, whereas this example had an air volume of 0.43 liter Zsec. Since the amount of chemical volatilization was 0.06 mgZhr, even when the same voltage was applied to the motor, the loss of air volume was greater in this example, but the amount of chemical volatilization was significant. As a result, it was confirmed that the location of the drug holder in the drug volatilization apparatus of the present invention is preferably on the inlet side.

[0062] Although the invention has been described in detail and with reference to specific embodiments, it will be apparent to those skilled in the art that various changes and modifications can be made without departing from the spirit and scope of the invention. is there.

This application is based on a Japanese patent application filed on Jan. 26, 2006 (Japanese Patent Application No. 2006-017914), the contents of which are incorporated herein by reference.

Claims

The scope of the claims

[1] a case having an intake port and an exhaust port;

A cross flow fan disposed in the case and connected to a rotating shaft of a motor; and a medicine holder disposed parallel to a longitudinal direction of the cross flow fan and disposed on the intake port side of the case. A chemical volatilization device characterized by that.

[2] The chemical volatilization device according to [1], wherein the intake port and the exhaust port are arranged at a position parallel to a longitudinal direction of the cross flow fan.

[3] The case is a portable cylindrical member, the cross-flow fan is arranged on one side in the longitudinal direction of the case, and the battery drives the motor on the other side in the longitudinal direction of the case. The chemical volatilization device according to claim 1 or 2, wherein:

[4] The drug volatilization apparatus according to any one of claims 1 to 3, wherein the case has an indicator for confirming a remaining amount of the drug in the drug holder.